Adicet Bio Inc reports results for the quarter ended in June - Earnings Summary

ADICET Bio

09/08/2023 23:22

* Adicet Bio Inc  ACET.OQ  reported a quarterly adjusted
loss
of 75 cents​​ per share for the quarter ended in June. The mean
expectation of ten analysts for the quarter was for a loss of 68
cents per share.
    * Reported revenue was zero​; analysts expected $12.67
million. 
    * Adicet Bio Inc's reported EPS for the quarter was a loss
of 75
cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Adicet Bio Inc shares had fallen by 9.5% this quarter and
lost 75.4% so far this year.
    * The company reported a quarterly loss of $32.4 million.
    * Wall Street's median 12-month price target for Adicet Bio
Inc is
$23.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 10:22 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.68          -0.75          Missed
 Mar. 31 2023      -0.69          -0.72          Missed
 Dec. 31 2022      -0.28          -0.72          Missed
 Sep. 30 2022      -0.53          -0.53          Met